منابع مشابه
Recently published papers: Therapies failed, disputed, and beneficent
A recent meta-analysis puts another nail in the coffin of a therapy that held great promise for management of acute respiratory distress syndrome. Two papers further highlight the growing controversy surrounding the safety profile of drotrecogin alpha (activated) and increase the clamour for a new independent trial. Also covered are steroids and their role in preventing postoperative atrial fib...
متن کاملRecently published papers: predictors, pressors and poietins
Simple, sensitive and specific predictors of mortality in the critically ill remain elusive goals, and brain natriuretic peptide and venous lactate are the subjects of recent studies. The role of vasopressin in sepsis continues to be the focus of much research interest. Dose ranging studies, potential adverse effects, and selective V1 agonists are discussed below in recent trials. Finally the u...
متن کاملRecently published papers: From superbugs to superbowl
Several papers are discussed including the CARP (Coronary Artery Revascularisation Prophylaxis) trial, examining the role, if any, of preoperative coronary revascularisation and a study examining the heart rate in the intensive care unit (ICU) population. We also take a look at infections in the ICU with particular regard to a recent study which examined isolating patients with methicillin-resi...
متن کاملRecently published papers: Pseudomonas, brain and bowel injury and novel cardiac therapies
Ventilator-associated pneumonia is a familiar foe in intensive care units, but those associated with Pseudomonas aeruginosa have a particularly adverse impact on outcome. Correct antibiotic therapy and a novel endotracheal tube may reduce this burden. Does activated protein C improve outcome from acute lung injury and what is the role played by hyperventilation therapy in traumatic brain injury...
متن کاملRecently published papers: Topical issues in pharmacology
The use of pharmacological agents in intensive care units (ICUs) is ever on the increase, with novel therapies appearing in the literature regularly. The complexities of polypharmacy are a challenge to the intensivist, and any guidance as to which drugs to use, when to use them and how much to use is always welcome. Happily, therefore, over the past 2 months a number of interesting papers and a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Critical Care
سال: 2007
ISSN: 1364-8535
DOI: 10.1186/cc5931